Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jeremy Jones, Andrew Macdonald

Premium

CombiMatrix has appointed Jeremy Jones to its board of directors, the Irvine, Calif.-based molecular diagnostics firm said this week.

Jones is currently chairman of On Assignment, a provider of professionals in the life sciences, healthcare, and technology sectors. He is also on the advisory board of MedidaMetrics. Jones was an investor in and chairman of home health service companies Byram Healthcare Centers and Lifecare Solutions until their sales in 2008 and 2011, respectively.

He has also served on the boards of US Labs, now part of Laboratory Corporation of America; Byram Healthcare, which was acquired by OPG in 2008; and Cardium Healthcare, which was acquired by CenCorp Health in 2006.


Liquid handling technology specialist Redd&Whyte has appointed Andrew Macdonald as head of tech services.

Macdonald joins Redd&Whyte from Genesis Diagnostics, where he was head of microarray technologies for seven years. He also worked at BioRobotics, now part of Genomic Solutions, as a global applications specialist.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.